相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The pathogenesis of the bone disease of multiple myeloma
Claire M. Edwards et al.
BONE (2008)
Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells
Jitesh Pratap et al.
CANCER RESEARCH (2008)
CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation
Hernan Roca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells (vol 118, pg 2180, 2008)
Hewang Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Histopathological assessment of prostate cancer bone osteoblastic metastases
Martine P. Roudier et al.
JOURNAL OF UROLOGY (2008)
VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta(3)-integrin
Quanli Yang et al.
MATRIX BIOLOGY (2008)
New wirings in the survivin networks
D. C. Altieri
ONCOGENE (2008)
Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone
Z. G. Li et al.
ONCOGENE (2008)
RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor, metastasis genes
Allison P. Armstrong et al.
PROSTATE (2008)
Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential
Sayyed K. Zaidi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular biology of bone metastasis
Lauren A. Kingsley et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer
Shinako Araki et al.
CANCER RESEARCH (2007)
Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation
Gregory A. Clines et al.
MOLECULAR ENDOCRINOLOGY (2007)
Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2
Daniel W. Young et al.
NATURE (2007)
Nuclear microenvironments in biological control and cancer
Sayyed K. Zaidi et al.
NATURE REVIEWS CANCER (2007)
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone
J. Pratap et al.
CANCER AND METASTASIS REVIEWS (2006)
Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP)
Jinhui Liao et al.
CANCER AND METASTASIS REVIEWS (2006)
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
Theresa A. Guise et al.
CLINICAL CANCER RESEARCH (2006)
Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo
Nagarajan Selvamurugan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Role of Wnts in prostate cancer bone metastases
CL Hall et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Matrix metalloproteinases and tumor metastasis
EI Deryugina et al.
CANCER AND METASTASIS REVIEWS (2006)
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer
Z Fu et al.
PROSTATE (2006)
Dual-color-coded imaging of viable circulating prostate carcinoma cells reveals genetic exchange between tumor cells in vivo, contributing to highly metastatic phenotypes
GV Glinsky et al.
CELL CYCLE (2006)
Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-κB ligand pathway
MS Bendre et al.
CANCER RESEARCH (2005)
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion
J Pratap et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
JS Shao et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: Role of cAMP-dependent protein kinase a signaling pathway
WC Huang et al.
CANCER RESEARCH (2005)
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer
G Morgia et al.
UROLOGICAL RESEARCH (2005)
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo
A Javed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prostate cancer bone metastases promote both osteolytic and osteoblastic activity
ET Keller et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein
JL Dai et al.
CANCER RESEARCH (2004)
Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines
M Zayzafoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dlx3 transcriptional regulation of osteoblast differentiation: Temporal recruitment of Msx2 Dlx3 an Dlx5 homeodomain proteins to chromatin of the osteocalcin gene
MQ Hassan et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease
GL Barnes et al.
CANCER RESEARCH (2004)
Fibronectin protects prostate cancer cells from tumor necrosis factor-α-induced apoptosis via the AKT/survivin pathway
M Fornaro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression
CK Inman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Osteoprotegerin and rank ligand expression in prostate cancer
JM Brown et al.
UROLOGY (2001)
分享论文
